All Pharma News
Lantheus Announces CEO Succession Plan

Lantheus Announces CEO Succession Plan
PRESS RELEASE
23 Jan 2024
Share Share
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA
PRESS RELEASE
11 Jan 2024
Share Share
42nd Annual J.P. Morgan Healthcare Conference

42nd Annual J.P. Morgan Healthcare Conference
PRESS RELEASE
10 Jan 2024
Share Share
Lantheus Reports Preliminary Fiscal Year 2023 Revenue

Lantheus Reports Preliminary Fiscal Year 2023 Revenue
PRESS RELEASE
09 Jan 2024
Share Share
Lantheus Expands Radiopharmaceutical Oncology Pipeline

Lantheus Expands Radiopharmaceutical Oncology Pipeline
PRESS RELEASE
09 Jan 2024
Share Share
Lantheus hands Perspective $28M upfront to expand its radiopharma options

Lantheus hands Perspective $28M upfront to expand its radiopharma options
Anna Brown ENDPTS
09 Jan 2024
Share Share
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRESS RELEASE
03 Jan 2024
Share Share
POINT Biopharma shareholders get long-awaited radioligand therapy data

POINT Biopharma shareholders get long-awaited radioligand therapy data
PRESS RELEASE
20 Dec 2023
Share Share
Lantheus and POINT Biopharma Announce Positive Results from SPLASH Trial

Lantheus and POINT Biopharma Announce Positive Results from SPLASH Trial
GLOBENEWSWIRE
18 Dec 2023
Share Share
Ratio Therapeutics Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical

Ratio Therapeutics Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical
PR NEWSWIRE
11 Jul 2023
Share Share